Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RDY will decline by -3.51% over the next 2 Weeks and hit $12.67 by Tuesday, April 28, 2026. In that time frame, RDY's share price is expected to range between $12.48 and $12.88.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 28, 2026 | 12.48 | 12.67 | 12.88 |
| Apr 27, 2026 | 12.48 | 12.67 | 12.88 |
| Apr 24, 2026 | 12.54 | 12.75 | 12.95 |
| Apr 23, 2026 | 12.66 | 12.86 | 13.07 |
| Apr 22, 2026 | 12.75 | 12.95 | 13.15 |
| Apr 21, 2026 | 12.74 | 12.93 | 13.15 |
| Apr 20, 2026 | 12.74 | 12.94 | 13.13 |
| Apr 17, 2026 | 12.81 | 13.01 | 13.20 |
| Apr 16, 2026 | 12.93 | 13.13 | 13.33 |
| Apr 15, 2026 | 13.02 | 13.22 | 13.42 |
RDY shares rose +1.39% in Thursday, April 16, 2026's trading session, rising from a previous close of $12.94 to move at $13.12. The stock demonstrated notable intraday movement (see RDY's key stats for a full breakdown), fluctuating between $12.99 and $13.13, a +1.04% trading range. While recent weeks have seen some volatility, RDY has managed to secure a -5.27% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 2.23M shares changing hands, 543.4K more than the previous session. This amounted to $29.24M in total market activity.
Will RDY Continue Its Downward Trend?
According to analyst ratings and projections for RDY, Dr. Reddy's Laboratories Limited shares are anticipated to decrease by -1.83%, potentially reaching $12.88 per share by April 28, 2026. Short-term technical indicators currently suggest a neutral sentiment for RDY. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 10 positive trading days within the past 30 sessions. Based on the RDY stock forecast, now is not the best time to buy RDY stock because its current trading price is +3.56% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on RDY covering social and institutional perspectives.
RDY Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RDY's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 40.57% to 41.54%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 45.01%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.93%, maintains a neutral outlook for the long term. Insights into RDY's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Dr Reddy's Laboratories Short-Term Forecasts
RDY Forecast For Next 5 Days
Our algorithm anticipates Dr Reddy's Laboratories (RDY) stock could hit $13.63 by Apr 23, 2026. This represents a +3.87% fall from today's price, following a -4.01% change over the past five days.
RDY Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Dr. Reddy's Laboratories Limited (RDY) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $13.86, which would mean a +5.64% increase from the current price of $13.12. Projections for this period range from a high of $14.88 to a low of $12.91.
RDY Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Dr Reddy's Laboratories's price over the next three months point to a rise. RDY stock is expected to peak at $29.11 on Jul 16, 2026 after potentially dipping to $24.79 on Jun 01, 2026. On average, RDY is likely to trade around $26.99 in the coming 90 days.
Dr Reddy's Laboratories Stock Forecast 2025
Based on our predictive models, Dr Reddy's Laboratories (RDY) is expected to trade between $20.26 and $38.57 throughout 2026. This would result in an average price of $27.74, potentially offering investors a +111.43% return from current levels.
Dr. Reddy's Laboratories Limited Monthly Forecast 2026–2027
April 2026
According to our latest forecast models, Dr. Reddy's Laboratories Limited (RDY) is positioned to show a strong performance in April 2026. The price is predicted to move between $28.28 and $29.00, settling at an average of $28.72. This could translate to a +118.90% gain.
May 2026
Based on current market signals, Dr. Reddy's Laboratories Limited is projected to trend may 2026. We forecast a trading range from $24.88 to $28.45, with a likely average price of $26.43. Investors could expect a potential return of +101.45%.
June 2026
Our predictive algorithms indicate Dr. Reddy's Laboratories Limited stock may see a shift in June 2026. The expected range spans $24.79–$28.00, with an average target of $26.25. This represents a positive outlook and a possible gain of +100.08%.
July 2026
Analyzing established trends, Dr. Reddy's Laboratories Limited looks set to move in July 2026. Projections place the stock between $27.26 and $30.47, averaging around $28.08. This suggests a +114.02% gain from current levels.
August 2026
Market indicators suggest Dr. Reddy's Laboratories Limited could experience notable changes during August 2026. Prices could fluctuate within $27.93 to $32.61, with a midpoint forecast of $29.63. The stock might deliver a +125.84% gain.
September 2026
Forecasting for September 2026, models estimate that Dr. Reddy's Laboratories Limited may undergo key fluctuations. If trends hold, the stock might trade between $24.83 and $32.97, averaging $29.11. This signals a positive trajectory with potential returns around +121.88%.
October 2026
According to our latest forecast models, Dr. Reddy's Laboratories Limited (RDY) is positioned to show a strong performance in October 2026. The price is predicted to move between $21.29 and $33.05, settling at an average of $27.30. This could translate to a +108.08% gain.
November 2026
Based on current market signals, Dr. Reddy's Laboratories Limited is projected to trend november 2026. We forecast a trading range from $20.98 to $35.11, with a likely average price of $26.50. Investors could expect a potential return of +101.98%.
December 2026
Our predictive algorithms indicate Dr. Reddy's Laboratories Limited stock may see a shift in December 2026. The expected range spans $20.26–$38.57, with an average target of $28.07. This represents a positive outlook and a possible gain of +113.95%.
January 2027
Analyzing established trends, Dr. Reddy's Laboratories Limited looks set to move in January 2027. Projections place the stock between $18.07 and $39.17, averaging around $28.44. This suggests a +116.77% gain from current levels.
February 2027
Market indicators suggest Dr. Reddy's Laboratories Limited could experience notable changes during February 2027. Prices could fluctuate within $16.84 to $41.17, with a midpoint forecast of $28.80. The stock might deliver a +119.51% gain.
March 2027
Forecasting for March 2027, models estimate that Dr. Reddy's Laboratories Limited may undergo key fluctuations. If trends hold, the stock might trade between $12.78 and $40.37, averaging $26.56. This signals a positive trajectory with potential returns around +102.44%.
April 2027
According to our latest forecast models, Dr. Reddy's Laboratories Limited (RDY) is positioned to show a strong performance in April 2027. The price is predicted to move between $12.24 and $39.29, settling at an average of $25.28. This could translate to a +92.68% gain.
RDY's history of dividends and stock splits also plays a role in long-term investor confidence.

